Neuromyelitis optica spectrum disorder (NMOSD), first described by Devic in 1894 [1] and previously considered a severe variant of multiple sclerosis (MS), is now recognized as a distinct autoimmune astrocytopathy mediated by aquaporin-4 (AQP4) antibodies [2,3]. Here, AQP4 is linked to myeloid sarcoma.